You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


COVID-19: Unpacking the Ongoing Challenge of Vaccine Hesitancy and Recommendations for Boosters in Pediatrics

  1. Which of the following statements best reflects best practices to communicate with a parent who is hesitant to vaccinate their son with an mRNA vaccine because they have heard it may cause myocarditis?
    Thank you for sharing those concerns, myocarditis is a minor concern that has been overhyped by the media
    Thank you for sharing those concerns, let’s compare the risk of developing myocarditis from the vaccine with the risk of myocarditis from COVID-19
    Let’s review the safety data for the mRNA vaccines, which suggest that, in 12- to 39-year-olds, the rate of myocarditis/pericarditis after the second dose was 12.6 cases per million
    Let’s discuss each of your concerns about this recommendation, and I will explain why the science does not concur
  2. Your patient is a 12-year-old girl who attends clinic for a well-child visit and school sports forms. After your examination, you broach the discussion of recommended vaccinations. She received a primary series with Pfizer-BioNTech and received a monovalent booster 6 months ago. What is the recommendation for COVID-19 booster for this patient?
    This patient is not eligible for a booster
    Receive booster now with mRNA bivalent booster
    Schedule vaccination in 6 months with mRNA monovalent booster
    Schedule vaccination in 6 months with mRNA bivalent booster